Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
03 janv. 2025 08h00 HE
|
Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference...
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
31 déc. 2024 07h00 HE
|
Galera Therapeutics
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer. Lead program is...
Nutriband Issues Letter to Shareholders
31 déc. 2024 07h00 HE
|
Nutriband Inc.
CEO Publishes Letter to Shareholders looking over achievements in 2024 and outlook for 2025
2024 Rising Stars Shine at iC³ Summit: Celebrating Progress and Setting the Stage for 2025
30 déc. 2024 10h59 HE
|
BioNTX
DALLAS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The 2024 Rising Stars of the life sciences and healthcare innovation sector took center stage at the iC³ Life Science Summit this year, marking another...
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
27 déc. 2024 09h25 HE
|
Nutriband Inc.
Chinese Patent for AVERSA extended to Macao
Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference
26 déc. 2024 12h21 HE
|
Tevogen Bio Inc
The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative...
Abivax Announces a Change to the Composition of its Board of Directors
23 déc. 2024 16h05 HE
|
Abivax
Abivax Announces a Change to the Composition of its Board of Directors PARIS, France, December 23, 2024, 10:05 PM CEST – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a...
Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference
23 déc. 2024 09h38 HE
|
Tevogen Bio Inc
WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
FibroBiologics Announces $25 Million Financing
23 déc. 2024 07h55 HE
|
Fibrobiologics, Inc.
HOUSTON, Dec. 23, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...
浩鼎、日本顶尖糖化学衍生技术公司 GlyTech 签署二协议
23 déc. 2024 04h00 HE
|
OBI Pharma Inc.
台湾台北, Dec. 23, 2024 (GLOBE NEWSWIRE) -- 台湾浩鼎(4174.TWO)23日发布，与日本专注于聚糖生产和糖化学衍生技术的GlyTech, Inc.，签署行销和材料移转两项协议；日后将借GlyTech之力，推广日本生技制药业采用浩鼎自主开发的GlycOBI® ADC (antibody-drug conjugate) 关键技术，以创造双赢，双方共享利益。 ...